176 related articles for article (PubMed ID: 21212139)
1. Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.
Feng B; Li Z; Wang JB
Mol Pharmacol; 2011 Apr; 79(4):768-75. PubMed ID: 21212139
[TBL] [Abstract][Full Text] [Related]
2. Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.
Birdsong WT; Arttamangkul S; Bunzow JR; Williams JT
Mol Pharmacol; 2015 Oct; 88(4):816-24. PubMed ID: 25934731
[TBL] [Abstract][Full Text] [Related]
3. Role of Phosphorylation Sites in Desensitization of µ-Opioid Receptor.
Yousuf A; Miess E; Sianati S; Du YP; Schulz S; Christie MJ
Mol Pharmacol; 2015 Oct; 88(4):825-35. PubMed ID: 25969388
[TBL] [Abstract][Full Text] [Related]
4. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
5. Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor.
Chen YJ; Oldfield S; Butcher AJ; Tobin AB; Saxena K; Gurevich VV; Benovic JL; Henderson G; Kelly E
J Neurochem; 2013 Jan; 124(2):189-99. PubMed ID: 23106126
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2014 Sep; 171(18):4273-88. PubMed ID: 24846673
[TBL] [Abstract][Full Text] [Related]
7. μ-Opioid receptor desensitization: homologous or heterologous?
Llorente J; Lowe JD; Sanderson HS; Tsisanova E; Kelly E; Henderson G; Bailey CP
Eur J Neurosci; 2012 Dec; 36(12):3636-42. PubMed ID: 23002724
[TBL] [Abstract][Full Text] [Related]
8. A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.
Huang P; Chen C; Mague SD; Blendy JA; Liu-Chen LY
Biochem J; 2012 Jan; 441(1):379-86. PubMed ID: 21864297
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.
Pak Y; O'Dowd BF; Wang JB; George SR
J Biol Chem; 1999 Sep; 274(39):27610-6. PubMed ID: 10488100
[TBL] [Abstract][Full Text] [Related]
10. Role of cytoplasmic tail of the type 1A angiotensin II receptor in agonist- and phorbol ester-induced desensitization.
Tang H; Guo DF; Porter JP; Wanaka Y; Inagami T
Circ Res; 1998 Mar; 82(5):523-31. PubMed ID: 9529156
[TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Czeta mediates micro-opioid receptor-induced cross-desensitization of chemokine receptor CCR5.
Song C; Rahim RT; Davey PC; Bednar F; Bardi G; Zhang L; Zhang N; Oppenheim JJ; Rogers TJ
J Biol Chem; 2011 Jun; 286(23):20354-65. PubMed ID: 21454526
[TBL] [Abstract][Full Text] [Related]
13. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling.
Ajit SK; Ramineni S; Edris W; Hunt RA; Hum WT; Hepler JR; Young KH
Cell Signal; 2007 Apr; 19(4):723-30. PubMed ID: 17126529
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
15. Role for the C-terminus in agonist-induced mu opioid receptor phosphorylation and desensitization.
Deng HB; Yu Y; Pak Y; O'Dowd BF; George SR; Surratt CK; Uhl GR; Wang JB
Biochemistry; 2000 May; 39(18):5492-9. PubMed ID: 10820022
[TBL] [Abstract][Full Text] [Related]
16. μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.
McPherson J; Rivero G; Baptist M; Llorente J; Al-Sabah S; Krasel C; Dewey WL; Bailey CP; Rosethorne EM; Charlton SJ; Henderson G; Kelly E
Mol Pharmacol; 2010 Oct; 78(4):756-66. PubMed ID: 20647394
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.
Bailey CP; Llorente J; Gabra BH; Smith FL; Dewey WL; Kelly E; Henderson G
Eur J Neurosci; 2009 Jan; 29(2):307-18. PubMed ID: 19200236
[TBL] [Abstract][Full Text] [Related]
18. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia.
Guang W; Wang H; Su T; Weinstein IB; Wang JB
Mol Pharmacol; 2004 Nov; 66(5):1285-92. PubMed ID: 15496510
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein kinase C prevents rapid desensitization of type 1B angiotensin II receptor.
Tang H; Shirai H; Inagami T
Circ Res; 1995 Aug; 77(2):239-48. PubMed ID: 7614710
[TBL] [Abstract][Full Text] [Related]
20. ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2.
Rankovic M; Jacob L; Rankovic V; Brandenburg LO; Schröder H; Höllt V; Koch T
Cell Signal; 2009 Dec; 21(12):1784-93. PubMed ID: 19666113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
